Tags: Coronavirus | covid-19 | vaccine | germany | research | trials | idt biologika

COVID-19 Vaccine Developed by German Research Group Fails in Early Trial

employee holds a syringe with the covid-19 vaccine and wears blue gloves
(Frank Molter/AP)

Friday, 08 January 2021 07:41 AM

A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for immune reaction in early-stage testing on humans, trial organizers at university hospital Hamburg-Eppendorf (UKE) said on Friday.

Further testing has been suspended until the cause for the weak immunogenicity in the Hamburg trial involving 30 volunteers has been established, UKE said in a statement, adding that the vaccine was well tolerated.

IDT said in November it was hoping to be able to apply for regulatory approval at the end of 2021.

© 2021 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
GlobalTalk
A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for immune reaction in early-stage testing on humans, trial organizers at university hospital Hamburg-Eppendorf (UKE) said on...
covid-19, vaccine, germany, research, trials, idt biologika
93
2021-41-08
Friday, 08 January 2021 07:41 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved